Kwangdong Healthbio Co., Ltd. (XKON:086220)
South Korea · Delayed Price · Currency is KRW 1,090.00
+80.00 (7.92%)
At close: Oct 2, 2026
Kwangdong Healthbio Market Cap
Kwangdong Healthbio has a market cap or net worth of 13.83 billion as of October 2, 2026. Its market cap has decreased by -8.47% in one year.
Market Cap
13.83B
Enterprise Value
n/a
Revenue
38.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,090.00
ChartMarket Cap Chart
Since April 5, 2017, Kwangdong Healthbio's market cap has decreased from 20.68B to 13.83B, a decrease of -33.11%. That is a compound annual growth rate of -4.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 13.83B | -30.75% |
| Dec 30, 2025 | 19.97B | 14.12% |
| Dec 30, 2024 | 17.50B | -38.70% |
| Dec 28, 2023 | 28.55B | 23.01% |
| Dec 29, 2022 | 23.21B | -12.02% |
| Dec 30, 2021 | 26.38B | -4.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HLscience | 26.53B |
| Baskhanbio Pharma | 25.20B |
| Seoul Pharma | 22.61B |
| Daesung Microbiological Labs. | 22.57B |
| BIFIDO | 21.68B |
| Hurum | 20.40B |
| Union Korea Pharm | 19.70B |
| WooGene B&G | 18.65B |